CAPR — Capricor Therapeutics Share News
0.000.00%
Last trade - 00:00- $356.39m
- $118.46m
U.S. STOCKS ON THE MOVE-Rocket Lab, silver miners, D-Wave Quantum
U.S. STOCKS ON THE MOVE-Rocket Lab, silver miners, D-Wave Quantum
U.S. STOCKS ON THE MOVE-Rocket Lab, silver miners, D-Wave Quantum
Capricor plummets after FDA flags concerns over its Duchenne therapy
FDA staff flags data concerns about Capricor's therapy; shares plunge (updated)
FDA staff flags concerns for Capricor's Duchenne heart disease therapy
Capricor tumbles as FDA panel meet for Duchenne cell therapy adds risk worries
Brief: Capricor Therapeutics Says Deramiocel BLA PDUFA Target Action Date Set For August 22
Brief: Capricor Therapeutics Reports First Quarter 2026 Financial Results
Capricor Therapeutics Q1 net loss widens as expenses rise
Capricor Theraputics Q4 revenue falls to zero, net loss widens
Brief: Capricor Therapeutics Q4 EPS USD -0.62
U.S. STOCKS ON THE MOVE-Nuwellis, Citigroup, Meta
U.S. STOCKS ON THE MOVE-GE Vernova, Atlas Energy, Citigroup
Capricor surges as FDA resumes review of muscle‑wasting disease drug
U.S. STOCKS ON THE MOVE-Hewlett Packard Enterprise, Dianthus, 3D Systems
U.S. STOCKS ON THE MOVE-Biotechs, Agilent, Dow
Biotechs gain as FDA vaccines chief's exit seen as easing regulatory pathway
Uniqure jumps after FDA vaccines chief Vinay Prasad to step down